• COMSCORE, Inc. SCOR shares tumbled 22.4 percent to $25.19 after the company disclosed that it has notified the Nasdaq Hearings Panel that it will be unable to regain compliance with its SEC periodic reporting requirements by the deadline date.
  • Aratana Therapeutics Inc PETX shares tumbled 16.8 percent to $6.68. Aratana Therapeutics reported that it projects ENTYCE to be commercially available in late 2017.
  • LGI Homes Inc LGIH dropped 11.3 percent to $27.80. LGI Homes disclosed that 172 homes closed in January 2017, down from 232 home closings in the year-ago period. Wells Fargo downgraded LGI Homes from Market Perform to Underperform.
  • Moleculin Biotech Inc MBRX fell 9.8 percent to $2.03.
  • Diffusion Pharmaceuticals Inc DFFN shares slipped 8.4 percent to $4.17. Diffusion Pharmaceuticals shares have dropped 68.62 percent over the past 52 weeks, while the S&P 500 index has gained 23.95 percent in the same period.
  • Xplore Technologies Corp. XPLR declined 8.3 percent to $2.00. Xplore Technologies shares have slipped 39.20 percent over the past 52 weeks, while the S&P 500 index has gained 23.95 percent in the same period.
  • Document Security Systems, Inc. DSS shares fell 7.6 percent to $1.21.
  • Newell Brands Inc NWL dropped 5.7 percent to $44.22. Newell Brands reported in-line earnings for its fourth quarter, while sales missed expectations.
  • Laboratory Corp. of America Holdings LH declined 4.4 percent to $131.66. Laboratory Corp. is in talks to acquire contract researcher Pharmaceutical Product Development LLC for more than $8 billion, according to sources as reported by Reuters on Friday. Baird downgraded Laboratory Corp. from Outperform to Neutral.
  • Vista Outdoor Inc VSTO dropped 4.4 percent to $25.03. DA Davidson downgraded Vista Outdoor from Buy to Neutral.
  • MYOS RENS Technology Inc MYOS shares fell 4.1 percent to $3.50 after surging 37.22 percent on Friday.
  • Calpine Corporation CPN dropped 4 percent to $11.19. Morgan Stanley downgraded Calpine from Overweight to Equal-Weight.
  • FMC Technologies, Inc. FTI shares declined 3 percent to $32.45. Jefferies initiated coverage on FMC Technologies with a Hold rating.
  • Tiffany & Co. TIF shares fell 2 percent to $79.07 after the company reported the resignation of its CEO Frederic Cumenal.
  • bluebird bio Inc BLUE shares slipped 2 percent to $77.22. Roth Capital downgraded bluebird bio from Buy to Neutral.
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!